Literature DB >> 15013148

Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand.

Y Gomez1, E Adams, J Hoogmartens.   

Abstract

In this study, 18 copies of PLAVIX tablets containing clopidogrel hydrogensulfate were compared to the innovator drug product for uniformity of mass, impurity profile, content, dissolution properties and stability. In order to be able to separate the R-enantiomer of clopidogrel, an enantiospecific liquid chromatographic method was used to determine the impurities and to perform the assay. The paddle method was used for dissolution testing. Most of the copies were not similar compared to the original drug product: their amount of impurities was higher, the content of clopidogrel lower, the dissolution profiles different and after 3 months under stress conditions in the original packaging, the results for the samples and the reference were significantly different in most of the cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013148     DOI: 10.1016/S0731-7085(03)00533-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  A comparison of two brands of clopidogrel in patients with drug-eluting stent implantation.

Authors:  Yae Min Park; Taehoon Ahn; Kyounghoon Lee; Kwen-Chul Shin; Eul Sik Jung; Dong Su Shin; Myeong Gun Kim; Woong Chol Kang; Seung Hwan Han; In Suck Choi; Eak Kyun Shin
Journal:  Korean Circ J       Date:  2012-07-26       Impact factor: 3.243

2.  Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

Authors:  Atholl Johnston; Roland Asmar; Björn Dahlöf; Kate Hill; David Albert Jones; Jens Jordan; Michael Livingston; Graham Macgregor; Michael Sobanja; Panagiotis Stafylas; Enrico Agabiti Rosei; José Zamorano
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

3.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

4.  Quantitative analysis of clopidogrel bisulphate and aspirin by first derivative spectrophotometric method in tablets.

Authors:  Madhuri D Game; K B Gabhane; D M Sakarkar
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

5.  Development and Validation of a Reversed-phase HPLC Method for Simultaneous Determination of Aspirin, Atorvastatin Calcium and Clopidogrel Bisulphate in Capsules.

Authors:  S V Londhe; R S Deshmukh; S V Mulgund; K S Jain
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

6.  Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand.

Authors:  Sukit Yamwong; Unchalee Permsuwan; Sirana Tinmanee; Piyamitr Sritara
Journal:  Health Econ Rev       Date:  2014-11-14

7.  Development of a new HPLC method for simultaneous determination of clopidogrel and its major metabolite using a chemometric approach.

Authors:  V Anuta; I Sarbu; I Mircioiu; B S Velescu
Journal:  Curr Health Sci J       Date:  2015-03-15

8.  Chemometric simultaneous estimation of clopidogrel bisulphate and aspirin from combined dosage form.

Authors:  S J Rajput; R K George; Deepti B Ruikar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

Review 9.  Substandard drugs: a potential crisis for public health.

Authors:  Atholl Johnston; David W Holt
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

10.  Simultaneous Analysis of Clopidogrel Bisulfate, Acetylsalicylic Acid and Atorvastatin calcium in Tablets by HPLC Method.

Authors:  A M Spiridon; J Neamtu; I Belu; T S Turcu-Stiolica; O Croitoru
Journal:  Curr Health Sci J       Date:  2015-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.